Persistent Systems. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Double Digit Growth With Better Margins Likely In FY19

Size: px
Start display at page:

Download "Persistent Systems. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Double Digit Growth With Better Margins Likely In FY19"

Transcription

1 Result Update Institutional Equities Persistent Systems Reuters: PERS.BO; Bloomberg: PSYS IN Double Digit Growth With Better Margins Likely In FY19 Persistent Systems (PSL) revenues were in line with our estimate, although the margins were better. The latter was because of: (1) IP revenue decline being not as sharp as was feared. (2) Write-back of variable pay because of non-achievement of internal targets. (3) Increase in realisation in both onsite and offshore services. (4) Higher employee utilisation in the services business. Services (~78% of revenues) grew 1.3%, while IP revenues (~22%) declined 20.6%, QoQ. The large fall in IP revenues on QoQ basis largely stemmed from its IBM relationship and can be attributed to timing difference rather than loss of revenues. IP revenues are expected to be recouped in FY19. While digital revenues of PSL have grown 36% YoY in in USD terms, the management believes that execution-related problems prevented it from growing much faster. PSL stated that it has taken corrective steps and believes FY19 could see the impact of these measures. One of them seems to be the merger of its digital and services businesses into an overarching Technology Services business. Accelerite, its non-ibm related IP business has seen a decline of ~9% on QoQ basis and ~31% YoY in revenue terms. This was attributed to Rcloud being shut down and the fact that some its mature products are witnessing lower sales. PSL hinted at purchase of a few products in this business during FY19. While PSL did not give any specific revenue guidance for FY19, it broadly indicated that growth should be in double digits. Margins are expected to be in line or slightly higher than in FY18. PSL indicated its commitment to remain focused on revenue growth and expects SG&A spending to remain high going into FY19. PSL indicated its CE/CLM business will show mid single-digit growth in FY19 (a climb down from ~10% growth hinted at earlier). This stems from the lack of adequate response from IBM sales channel (see our earlier report in this regard: IP Growth Strategy Faces Valuation Threat). There is also an attempt to go direct to these product customers and hence PSL has hired 10 sales persons in Europe the geography which has maximum traction for its CE/CLM product. The higher Investment in sales is likely to translate into incremental revenues across the board and not just in its IP business. Post results, we maintain our estimates for FY19/FY20/FY21. We have upgraded our rating on the stock to Accumulate (from Sell earlier) solely because of the correction in its stock price driven by disappointment in IP sales. This incident highlights risks inherent in the business model of mid-cap companies which have very high client concentration that could lead to volatility in revenue growth and margins. Our target price on PSL is Rs717 (14.3x FY20E EPS, 30% discount to the target P/E multiple of TCS). The discount, we believe, is for the weak business model and lack of revenue predictability. Thus, while we have changed our recommendation on the stock to Accumulate, we are not necessarily very enthused about the company s performance/prospects. IP and low annuity revenues in services hamper visibility on growth: PSL is dependent to a very large extent on its partners like IBM to push its IP-related sales (although it is currently investing in building a direct sales channel). Similarly, its services business has low annuity streams in it which is likely to prevent the company from making a firm commitment on growth in FY19, despite a strong demand scenario. 25 April 2018 ACCUMULATE Sector: Information Technology CMP: Rs726 Target Price: Rs717 Downside: 1% Girish Pai Head of Research girish.pai@nirmalbang.com Key Data Current Shares O/S (mn) 80.0 Mkt Cap (Rsbn/US$mn) 58.1/ Wk H / L (Rs) 878/558 Daily Vol. (3M NSE Avg.) 280,774 Price Performance (%) 1 M 6 M 1 Yr Persistent Systems (7.2) Nifty Index Source Bloomberg Y/E March (Rsmn) YoY (%) QoQ (%) E Dev (%) Net Sales (USD mn) (4.6) Net Sales 7,271 7,919 7, (5.0) 7, Direct Cost 4,644 5,009 4, (1.8) 4, % of Sales SG&A 1,440 1,535 1, (2.5) 1,596 (6.2) % of Sales EBITDA 1,188 1,375 1,111 (6.5) (19.2) 1, EBITDA Margin (%) Depreciation and Amortisation EBIT (13.1) (29.8) EBIT Margin (%) Other Income, Net (.5) (6.0) Forex Gain/(Losses) (28) 50 0 (641.4) PBT 937 1, (16.3) Provision for Tax (4.7) Effective Tax Rate PAT (19.6) NPM (%)

2 Exhibit 1: Key financials Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Revenue (Rsmn) 28,784 30,337 35,329 38,183 39,977 YoY Growth (%) EBIT (Rsmn) 3,049 3,102 4,132 4,165 4,311 % of sales Adj. PAT (Rsmn) 3,0 3,231 3,897 4,019 4,245 YoY Growth (%) FDEPS (Rs) RoE (%) RoCE (%) RoIC (%) P/E (x) P/BV (x) Exhibit 2: Change in our Estimates New Old Change (%) Change in Estimates FY19E FY20E FY21E FY19E FY20E FY21E FY19E FY20E FY21E INR/USD USD Revenue (USD mn) (1.1) Revenue (Rsmn) 35,329 38,183 39,977 35,320 37,860 40, (1.1) EBIT (Rsmn) 4,132 4,165 4,311 4,066 4,196 4, (0.7) 0.7 EBIT Margin (%) PAT (Rsmn) 3,897 4,019 4,245 3,852 3,910 4, FDEPS (Rs) View on the sector: We recently turned tactically positive on Indian IT services sector for the next 12 months after having been negative on it for close to three years (see the report here). This change in stance has been driven by: (1) A modest growth pick-up because of a peaking developed market economic cycle in 2018 that has also been boosted by US tax reforms. (2) Large underweight institutional positioning in the sector. (3) Continued strong domestic equity flows. (4) Near-term negative news flow on financials (a large overweight sector for institutions). (5) Better relative valuation (which is no longer as compelling as it was three to four months ago). Around 80% of the upward revision in our coverage universe s expected market capitalisation has been from P/E multiple expansion and only 20% has come from a revision in earnings. The P/E multiple expansion has been/will be driven by paucity of investment options because of continued strong inflow of domestic money into equities, expensive valuation of popular themes (private financials, consumer staples, consumer discretionary, etc) and near-term challenges faced by financials from higher interest rates and higher stressed asset provisioning. Having said that, structurally, we believe that earnings growth of Tier-1 companies will be in mid-high single-digit at best over FY18-FY20E, and also believe the sector is still not an attractive bet for long-term investors looking for fast earnings compounders. Structural pressures that we have been harping on for the past three years will continue to constrain growth. These include value compression and cannibalisation from automation (which is reaching enterprise scale, in our view, countering the upside from digital projects which are also scaling up) and movement to cloud, and a weaker but improving competitive position in new areas, insourcing, etc. These pressures have led to growth pick-up being pushed back to the last stage of this economic upcycle. The street is anticipating a uniform pickup in growth over FY18-FY20E across Tier-1 companies. We disagree and believe that growth will be dispersed in FY19. In our coverage universe, we believe TCS and HCL Technologies will outperform their Tier-1 peers in organic revenue growth. Contrary to consensus expectations, we expect Infosys to disappoint on the growth front in FY19. For Wipro and Tech Mahindra, organic growth, in our view, will remain muted. We prefer large-caps over mid-caps at current valuations. Mid-caps may witness faster growth pick-up on a low base in FY19 (and from bombed-out margins in some cases), but would advise investors to focus on sustainability and not overpay for a riskier business model. Current valuations of mid-cap stocks factor in strong growth over a two to three-year time frame - which we believe is unlikely. Support will be provided by aggressive capital return policies of many companies in the medium term. 2 Persistent Systems

3 Exhibit 3: Geography-based USD QoQ and YoY revenue growth (%) in Geographies Contribution to revenues (%) USD growth-qoq (%) USD growth-yoy(%) North America 80.9 (8.5) 0.3 Europe India ROW Total (4.6) 7.3 Exhibit 4: Segment-based USD QoQ and YoY growth (%) in Segment Contribution to revenues (%) USD growth-qoq (%) USD growth-yoy(%) Services Digital Alliance 24.3 (21.6) (5.6) Accelerite 6.2 (9.0) (30.7) Total (4.6) 7.3 Exhibit 5: Vertical-based USD QoQ and YoY revenue growth (%) in Vertical Contribution to revenues (%) USD growth-qoq (%) USD growth-yoy (%) ISV Enterprise IP led (20.6) (13.3) Total (4.6) 7.3 Highlights of results and analyst call PSL s revenues of US$116.95mn were down 4.6% QoQ and up 7.3% YoY, respectively, and in line with our expectation of US$116.7mn. Services (~77.7% of revenues) grew 1.3%, while IP revenues (~22.3% of revenues) declined 20.6% QoQ. There was a sharp decline in the Accelerite business (~9% QoQ and ~30.7% YoY) as Rcloud business (migration products) was shut down and the location-based products witnessed a slowdown. The growth in services (up 1.3% in USD terms on QoQ basis) was largely because of the increase in realisation. The management indicated that linear revenues grew 1.3% on QoQ basis. This was on account of an increase in billing rates by 2.8% and reduction in volume by 1.5%. Onsite linear revenues increased 1.2% on account of the hike in billing rate by 2.1% and reduction in volume by 0.9%. Offshore linear revenues grew 1.4% on account of the increase in billing rate by 3% and reduction in volume by 1.6%. EBIT margin declined 320bps QoQ to 9.2% in versus 12.4% in and was better than our expectation of 8.3%. The factors that led to better-than-expected margin are as follows: (1) Improvement in employee utilisation rate (81.2% in vs. 79.9% in ). (2) Increase in realisation for both onsite and offshore work. (3) Write-back of variable payout following non- delivery of internal targets. PSL s management stated that it has merged various service units where the services complemented each other in a project under one head called Technology Service Unit (TSU) with Mr. Sudhir Kulkarni being made responsible for both - delivery as well as sales - for the unit. The digital segment (which constitutes ~24.0% of PSL s revenues) grew 4.1%/36.2% on QoQ and YoY basis, respectively, in USD terms in. However, the management indicated that PSL could have grown quicker had it not faced execution challenges despite having relevant capabilities. The poor execution was a result of people-related problems where growth expectations from partner relationships were not met. The management stated that it has taken steps to improve efficiency which will be visible in 1QFY19 and 2QFY19. We wonder if these execution problems have to do with the very high utilisation of it delivery staff. EBITDA margin for stood at 14.8% as against 17.4% in. The drop in margin on QoQ basis was on account of a seasonally strong and a higher-than-expected drop in IP-related revenues. However, in the opinion of the management, such a dip in revenues is one-off event and some part of the lost business is expected to come back in subsequent quarters. 3 Persistent Systems

4 1QFY13 Institutional Equities Employee utilisation stood at ~81.2% in on account of the decline in headcount. The management stated that the headcount will gradually increase over subsequent quarters. However, the incremental cost of increase in headcount will be offset by the increase in sales, thereby keeping operational efficiency and margins intact. The management has maintained its revenue growth guidance which is to beat industry body Nasscom s growth guidance of 7%-9% on account of a strong order pipeline and stable demand environment. It indicated that FY19 will turn out better than FY18. The management indicated that it will invest in sales rather than product development. The management believes that PSL has enough products to offer to the market and the market is now ready to buy them. The investment will not result in margin reduction. Increased sales will set off the pressure on margins because of investments. The management also stated that it added 10 sales persons in European market which will lead to better control over the sale of CE/CLM and other IBM products and hence translate into better sales. Investment in sales is expected to translate into incremental revenues across the board and not just in a specific segment of its business. PSL s technical headcount declined by 479 to 8,329 in from 8,808 in. The management did not give any guidance on wage hike percentage for employees. However, it stated that the wage hike cycle of FY18 will continue in FY19 (1 July 2018). PSL has appointed Prof. Deepak B. Phatak, recipient of Padma Shri award, who recently retired as a professor of computer science at IIT, Mumbai, and also Mr. Guy Eiferman who is an expert in life sciences and healthcare having held several important positions at Merck & Co., as additional directors (independent members) on its board with immediate effect. PSL s board announced a final dividend of Rs3/share in, thereby taking the total dividend to Rs10/share in FY18. Exhibit 6: USD revenue growth (YoY) has been decelerating since (%) Persistent Systems

5 1QFY13 1QFY13 1QFY13 1QFY13 1QFY13 Institutional Equities Exhibit 7: Onsite/ Offshore revenue mix (%) Onsite revenue mix (%) Offshore revenue mix Exhibit 8: IP continues to contribute a large part of the revenue mix though there was a dip in the quarter Exhibit 9: EBIT margin moves down on account of weak IP led sales (%) IP Mix (%) Gross Margins EBIT Margins SGA Exhibit 10: Attrition rate remains the same for and Exhibit 11: Employee utilisation at its highest level (%) Attrition (TTM %) (%) Blended Utilization (%) Persistent Systems

6 1QFY13 1QFY13 1QFY13 Institutional Equities Exhibit 12: Onsite rates move up a tad 18,000 Onsite billing rate 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 Exhibit 13: Offshore rate also perks up 4,400 Offshore billing rate 4,300 4,200 4,100 4,000 3,900 3,800 3,700 3,600 Exhibit 14: Decline in >US$3mn large clients on a QoQ basis Large Clients > $ 3Mn Persistent Systems

7 Exhibit : Quarterly snapshot Year to 31 March (Rsmn) INR/USD USD Revenue (USD mn) INR Revenue 6,771 7,018 7,040 7,455 7,271 7,280 7,613 7,919 7,525 Gross Margin 2,418 2,433 2,502 2,704 2,627 2,497 2,618 2,910 2,607 SGA 1,344 1,376 1,394 1,518 1,440 1,453 1,461 1,535 1,497 EBITDA 1,074 1,058 1,108 1,187 1,188 1,044 1,8 1,375 1,111 Dep & Amorization EBIT Other income (net) PBT 1, , ,019 1,1 1, Tax PAT YoY Growth (%) USD Revenue INR Revenue Gross Profit (0.7) EBIT 5.2 (3.7) (5.2) (7.4) (3.0) (8.8) (13.1) Net Profit (9.9) QoQ Growth (%) USD Revenue (0.9) (4.6) INR Revenue (2.5) (5.0) EBIT (5.3) (12.6) (0.8) (17.9) (29.8) Net Profit 4.3 (9.3) (11.1) (19.6) Margins (%) Gross Margin SGA EBITDA EBIT PBT PAT Persistent Systems

8 Exhibit 16: Key metrics Key Metrics P and L (USD mn) Revenue EBIT PAT P and L (Rsmn) Revenue 6,771 7,018 7,040 7,455 7,271 7,280 7,613 7,919 7,525 EBITDA 1,074 1,058 1,108 1,187 1,188 1,044 1,8 1,375 1,111 PAT Vertical Mix (%) Telecom Infrastructure and Systems Life Sciences & Healthcare Financial Services Segment Revenue Mix (%) Services Digital Alliance accelerite Geographical Mix (%) North Americas Europe Asia-Pacific Project Type (%) Services IP driven Utilization (%) (including Trainees) Revenue Mix (Delivery of IT services) Revenue mix-onsite Revenue mix-offshore Clients Concentration (%) Top client Top 5 clients Top 10 clients Number of Client > USD 3 mn+ clients >1 USD mn+ to <3 USD mn+ clients Employees 9,264 9,389 9,305 9,229 9,460 9,401 9,246 9,109 8,976 Attrition (%) Persistent Systems

9 Exhibit 17: QoQ and YoY data on various parameters QoQ Growth (%) Goegraphy North Americas (2.3) (1.4) 6.1 (1.0) (8.5) Europe (4.2) (8.4) (19.0) 17.8 (9.1) (0.9) (10.9) 7.2 Asia-Pacific (19.0) (10.6) (4.9) 17.9 (20.6) 29.7 (4.0) (68.0) (0.9) 7.6 (3.2) Segmental Telecom (11.7) 20.9 (5.2) (0.2) 1.9 (9.6) (6.5) 32.6 (6.6) Infrastructure and Systems 7.9 (23.7) (1.4) (1.7) Life Sciences & Healthcare (1.1) Financial Services (1.3) Segmental(New Classification) Services (1.7) (1.5) (0.9) (0.5) 3.6 Digital (1.3) Alliance (1.6) 8.9 (10.6) 9.6 (2.3) 12.5 (21.6) accelerite (10.4) 2.0 (16.7) (9.0) Industry Wise ISV (0.2) (2.5) 5.9 (3.1) (1.8) 0.1 (2.3) Enterprise IP led (4.7) 0.5 (7.1) (1.0) 6.9 (3.7) 2.1 (0.1) 6.9 (20.6) Project Type Services 1.6 (0.5) (1.5) IP driven (4.7) 0.5 (7.1) (1.0) 6.9 (3.7) 2.1 (0.1) 6.9 (20.6) Client Concentration Top (1.4) (4.1) (4.0) (5.7) (1.7) 8.7 (11.0) 9.1 (3.0) 12.2 (26.0) Top (1.7) (2.0) 1.0 (2.6) (0.5) 8.6 (6.7) (.7) Top (3.5) 2.3 (2.3) (4.9) (13.9) YoY Growth (%) Goegraphy North Americas Europe (14.1) Asia-Pacific (23.0) (14.5) (62.0) (60.8) (62.7) (67.0) Segmental Telecom (21.5) (12.9) (14.1) Infrastructure and Systems 25.9 (8.9) (9.8) (8.7) (16.7) Life Sciences & Healthcare Financial Services Segmental (New Classification) Services Digital Alliance (5.6) accelerite (.8) (30.7) Industry Wise ISV (0.1) (1.6) 1.7 (0.7) (3.1) Enterprise IP led (0.5) (10.2) (13.3) Project Type Services IP driven (0.5) (10.2) (13.3) Client Concentration Top (5.8) 0.5 (14.4) (5.9) (12.2) Top (5.3) Top (2.5) Persistent Systems

10 Mar-11 Jul-11 Oct-11 Feb-12 Jun-12 Sep-12 Jan-13 May-13 Aug-13 Dec-13 Apr-14 Aug-14 Nov-14 Mar- Jul- Oct- Feb-16 Jun-16 Oct-16 Jan-17 May-17 Sep-17 Dec-17 Apr-18 Mar-11 Jul-11 Dec-11 Apr-12 Sep-12 Jan-13 Jun-13 Oct-13 Mar-14 Jul-14 Dec-14 Apr- Sep- Jan-16 May-16 Oct-16 Feb-17 Jul-17 Nov-17 Apr-18 Mar-11 Jul-11 Dec-11 Apr-12 Sep-12 Jan-13 Jun-13 Oct-13 Mar-14 Jul-14 Dec-14 Apr- Sep- Jan-16 May-16 Oct-16 Feb-17 Jul-17 Nov-17 Apr-18 Institutional Equities Exhibit 18: P/E charts (Rs) 1,400 1,200 1, (x) Price P/E 7-yr mean 1sd -1sd Exhibit 19: P/E premium/(discount) to TCS (x) (10) (20) (30) (40) (50) (60) (70) PSL's 1-Yr fwd P/E discount to TCS Persistent Systems

11 Exhibit 20: Comparative valuation TCS Infosys Wipro HCL Tech TechMahindra Mindtree Persistent Year Ending March March March March March March March 4/25/2018 3,386 1, , , Currency INR INR INR INR INR INR INR Market Value (RsBn) 6,516 2,509 1,378 1, (US$mn) 101,023 38,900 21,365 22,920 9,253 2, March 2019 Target Price 3,176 1, , Upside/(downside) -6.2% 0.2% 5.2% -1.3% -10.9% -42.3% -1.2% Recommendation Accumulate Accumulate Accumulate Accumulate Accumulate Sell Accumulate FDEPS (Rs) FY FY FY18E FY19E FY20E PE (x) FY FY FY18E FY19E FY20E EV/EBITDA (x) FY FY FY18E FY19E FY20E EV/Sales (x) FY FY FY18E FY19E FY20E RoIC (%) FY FY FY18E FY19E FY20E Source: Bloomberg, Nirmal Bang Institutional Equities Research 11 Persistent Systems

12 Financials Exhibit 21: Income statement Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Average INR/USD Net Sales (USD mn) YoY Growth (%) (1.1) Net Sales 28,784 30,337 35,329 38,183 39,977 YoY Growth (%) Cost of Sales & Services 18,518 19,704 22,465 24,348 25,470 % of sales Gross Margin 10,266 10,633 12,864 13,835 14,507 % of sales SG& A 5,727 5,946 7,019 7,653 8,045 % of sales EBITDA 4,539 4,687 5,845 6,182 6,462 % of sales Depreciation 1,490 1,585 1,713 2,017 2,1 EBIT 3,049 3,102 4,132 4,165 4,311 % of sales Other income (net) 958 1,190 1,064 1,193 1,350 PBT 4,007 4,292 5,196 5,358 5,661 -PBT margin (%) Provision for tax 992 1,062 1,299 1,340 1,4 Effective tax rate (%) Net profit 3,0 3,231 3,897 4,019 4,245 -Growth (%) Net profit margin (%) Exhibit 23: Balance sheet Y/E March (Rsmn) FY17 FY18 FY19E FY20E FY21E Equity capital Reserves & surplus 18,193 20,472 22,960 25,042 27,241 Net worth 18,993 21,272 23,760 25,842 28,041 Deferred tax liability Other liabilities Total loans Total liabilities 19,291 21,448 23,937 26,018 28,218 Goodwill Net block (incl CWIP) 5,573 5,097 4,603 3,854 3,021 Investments 6,839 8,797 8,797 8,797 8,797 Deferred tax asset Other non-current assets Other current assets 3,411 4,585 5,201 5,209 5,389 Debtors 4,754 4,847 6,139 6,149 6,368 Cash & bank balance 1,510 2,414 4,052 6,874 9,699 Total current assets 9,675 11,846,392 18,231 21,457 Total current liabilities 4,173 4,870 5,433 5,441 5,636 Net current assets 5,502 6,976 9,959 12,790,822 Total assets 19,291 21,448 23,937 26,018 28,218 Exhibit 22: Cash flow (Y/E March) FY17 FY18 FY19E FY20E FY21E EBIT 3,049 3,102 4,132 4,165 4,311 (Inc.)/dec. in working capital (1,762) (570) (1,345) (9) (206) Cash flow from operations 1,287 2,532 2,787 4,7 4,105 Other income 958 1,190 1,064 1,193 1,350 Depreciation & amortisation 1,490 1,585 1,713 2,017 2,1 Tax paid (992) (1,062) (1,299) (1,340) (1,4) Dividends paid (761) (800) (1,409) (1,937) (2,046) Net cash from operations 1,982 3,445 2,856 4,090 4,144 Capital expenditure 1,650 1,027 1,218 1,268 1,319 Net cash after capex 332 2,419 1,638 2,822 2,825 Inc./(dec.) in debt 127 (136) (Inc.)/dec. in investments 135 (1,145) Equity issue/(buyback) Cash from financial activities 261 (1,280) Others (5) (234) Opening cash 1,432 1,510 2,414 4,052 6,874 Closing cash 1,510 2,414 4,052 6,874 9,699 Change in cash ,638 2,822 2,825 Exhibit 24: Key ratios Y/E March FY17 FY18 FY19E FY20E FY21E Per Share (Rs) EPS FDEPS Dividend Per Share Book Value Dividend Payout Ratio (%) Return ratios (%) RoE RoCE ROIC Tunover Ratios Asset Turnover Ratio Debtor Days (incl. unbilled Rev) Working Capital Cycle Days Valuation ratios (x) PER P/BV EV/EBTDA EV/Sales M-cap/Sales Dividend Yield Persistent Systems

13 Apr- May- Jun- Jul- Aug- Sep- Oct- Nov- Dec- Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 21 September 20 Sell October 20 Sell December 20 Sell January 2016 Under Review January 2016 Under Review March 2016 Sell March 2016 Sell April 2016 Sell June 2016 Sell July 2016 Sell October 2016 Sell December 2016 Sell January 2017 Sell January 2017 Sell February 2017 Sell April 2017 Sell June 2017 Sell July 2017 Sell September 2017 Sell October 2017 Sell December 2017 Sell December 2017 Under Review January 2018 Under Review March 2018 Sell April 2018 Accumulate Rating track graph Not Covered Covered 13 Persistent Systems

14 DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I/We, Mr. Girish Pai the research analysts is the author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 14 Persistent Systems

15 Disclaimer Stock Ratings Absolute Returns BUY > % ACCUMULATE -5% to% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com , Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com /8101, Michael Pillai Dealing Desk michael.pillai@nirmalbang.com /8103, Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai Board No. : /1; Fax. : Persistent Systems

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Indian Oil Corporation

Indian Oil Corporation 3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution 2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of

More information

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY 3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY Event Update Institutional Equities NESCO 27 August 2018 Reuters: NSEN.NS; Bloomberg: NSE IN Revenues From Bombay Exhibition Centre May Take A Hit This event update relates to an application made on 14

More information

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Institutional Equities Bata India 23 July 2018 Reuters: BATA.BO; Bloomberg: BATA IN Strong Margin Improvement To Drive Consensus EPS Upgrade Bata India s (BIL) YoY net sales growth

More information

EBITDA 5,076 3, , EBITDA

EBITDA 5,076 3, , EBITDA Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to

More information

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018 4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the

More information

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL 3QFY18 Result Update Institutional Equities Thermax 8 February 2018 Reuters: THMX.BO; Bloomberg: TMX IN Healthy Execution, But Margins Disappoint Thermax posted healthy execution in 3QFY18 with standalone

More information

Indian Oil Corporation

Indian Oil Corporation 4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)

More information

Punjab National Bank

Punjab National Bank 4QFY18 Result Update Institutional Equities Punjab National Bank 16 May 2018 Reuters: PNB.BO; Bloomberg: PNB IN Prompt Corrective Action Looms Punjab National Bank (PNB) reported its 4QFY18 results with

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Aurobindo Pharma 13 August 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN One-offs Impact Margin Aurobindo Pharma (APL) reported 1QFY19 revenues of Rs42,503mn which

More information

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN 2QFY19 Result Update Maruti Suzuki India 26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN Better-than-expected Margins; Retain Buy Maruti Suzuki India (MSIL) s 2QFY19 earnings were 18% above our estimate

More information

Institutional Equities

Institutional Equities 3QCY18 Result Update Institutional Equities Cognizant Technology Solutions 31 October 2018 Bloomberg: CTSH US A Rather Tame End To What Should Have Been A Great Year Post its 3QCY2018 results (which was

More information

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19% 1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven

More information

Institutional Equities

Institutional Equities 2QCY18 Result Update Institutional Equities Cognizant Technology Solutions 3 August 2018 Bloomberg: CTSH US No Upward Revision To Guidance As It Picks Its Battles Despite being in one of the best demand

More information

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Institutional Equities

Institutional Equities 3QFY18 Result Update Institutional Equities Atul Auto 15 February 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Drag Profitability Atul Auto s (AAL) 3QFY18 earnings missed our expectations

More information

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY Conference Update Institutional Equities Mold-Tek Packaging 20 August 2018 Reuters: MOLT.BO; Bloomberg: MTEP IN Promising Growth Outlook We recently interacted with the management of Mold-Tek Packaging

More information

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE 1QFY19 Result Update Voltas 13 August 218 Reuters: VOLT.BO; Bloomberg: VOLT IN EMPS Shines, UCP Proves Its Mettle Again Voltas reported consolidated revenues of Rs21.5bn for 1QFY19, up 11% YoY and 5%/6%

More information

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy 2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues

More information

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating

More information

Punjab National Bank

Punjab National Bank Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate

More information

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated Management Meet Update Institutional Equities Persistent Systems 22 June 2016 Reuters: PERS.BO; Bloomberg: PSYS IN Watson IOT Bet Risk/Reward More Muted Than Anticipated We had a meeting with Persistent

More information

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady

More information

Wipro. Institutional Equities. 4QFY18 Result Update ACCUMULATE. FY19 Likely To Be Yet Another Year Of Growth Underperformance

Wipro. Institutional Equities. 4QFY18 Result Update ACCUMULATE. FY19 Likely To Be Yet Another Year Of Growth Underperformance 4QFY18 Result Update Institutional Equities Wipro 26 April 2018 Reuters: WIPR.BO; Bloomberg: WPRO IN FY19 Likely To Be Yet Another Year Of Growth Underperformance Wipro s 4QFY18 IT services revenues grew

More information

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL 3QFY19 Result Update TVS Motor Company 23 January 2019 Reuters: TVSM.BO; Bloomberg: TVSL IN Better-Than-Expected Margins TVS Motor Company s 3QFY19 performance was above our expectations as it reported

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Dr. Reddy s Laboratories 27 July 2018 Reuters: REDY.BO; Bloomberg: DRRD IN Drug Pipeline In Place, But Regulatory Hurdles Testing Patience Dr. Reddy s Laboratories

More information

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA 1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance

More information

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN Management Meet Update Institutional Equities Eicher Motors 17 July 2018 Reuters: EICH.NS; Bloomberg: EIM IN We had a meeting with the management of Eicher Motors (EML) recently. Following are the key

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN 4QFY18 Result Update Institutional Equities Karnataka Bank 17 May 2018 Reuters: KBNK.NS; Bloomberg: KBL IN Plucky Bank And Low Hanging Fruit Karnataka Bank (KBL) reported 4QFY18 results with the key strategic

More information

Tech Mahindra. Institutional Equities. 2QFY19 Result Update ACCUMULATE

Tech Mahindra. Institutional Equities. 2QFY19 Result Update ACCUMULATE Result Update Institutional Equities Tech Mahindra 31 October 18 Reuters: TEML.BO; Bloomberg: TECHM IN Margins Continue To Surprise; Revenues And DSOs Disappoint The performance of Tech Mahindra (TML)

More information

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport 3QCY17 Result Update Institutional Equities Crisil 18 October 2017 Reuters: CRSL.BO; Bloomberg: CRISIL IN Weak SME Rating Revenues & Currency Movement Play Spoilsport Crisil s 3QCY17 performance was below

More information

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE Event Update Institutional Equities ACC 19 December 218 Reuters: ACC.BO; Bloomberg: ACC IN Capacity Expansion To Consolidate Presence In Central India ACC has announced 5.9mt capacity expansion by adding

More information

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely 4QFY15 Result Update Crompton Greaves 29 May 2015 Reuters: CROM.BO; Bloomberg: CRG IN Overseas Losses Continue; More Business Exits Likely The 4QFY15 performance of Crompton Greaves (CGL) was below expectation

More information

Institutional Equities

Institutional Equities Economy Update August CPI Inflation/ July IIP 14 September 2018 CPI Inflation Moderates To 3.69% YoY; IIP Growth Slows To 6.6% YoY Consumer Price Index or CPI inflation stood at 3.69% in August 2018, below

More information

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained

More information

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update 4QFY18 Result Update Institutional Equities Hindustan Unilever 15 May 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Reaping Rewards Of Consistency 4QFY18 was the third consecutive quarter wherein Hindustan

More information

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE 4QFY18 Result Update Institutional Equities Dabur India 3 May 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Growth Volatility Is Still Fairly High Dabur India s (DABUR) consolidated top-line performance in

More information

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities CARE Ratings 17 November 217 Reuters: CREI.BO; Bloomberg: CARE IN Mixed Performance CARE Ratings (CARE) reported an increase of 12.3% in revenues for 2QFY18

More information

Bharat Financial Inclusion

Bharat Financial Inclusion 3QFY18 Result Update Bharat Financial Inclusion Reuters: BHAF.NS; Bloomberg: BHAFIN IN 31 January 2018 Customer Acquisition Accelerates Meaningfully Bharat Financial Inclusion (BFIL) reported its 3QFY18

More information

Institutional Equities

Institutional Equities Economy Update March CPI Inflation/February IIP 15 April 2019 CPI Inflation Inches Up To 2.86%; IIP Growth Plunges To 0.1% Consumer Price Index or CPI inflation in March 2019 stood at 2.86%, slightly above

More information

Tata Consultancy Services

Tata Consultancy Services 4QFY15 Result Update Institutional Equities Tata Consultancy Services Reuters: TCS.BO; Bloomberg: TCS IN 17 April 215 Standalone P/E to crunch; P/E premium will depend on peers Tata Consultancy Services

More information

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018 4QFY18 Result Update Institutional Equities PNB Housing Finance 4 May 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Continued Display of Embedded Scalability PNB Housing Finance (PNBHF) reported 4QFY18

More information

Institutional Equities

Institutional Equities December 2017 Quarter Result Preview Institutional Equities Oil & Gas Sector 8 January 2018 Higher Crude Oil Prices To Result In Inventory Gains We expect 60%/4.4%/3.7%/6.5% QoQ growth in the December

More information

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Hindustan Unilever 17 July 218 Reuters: HLL.BO; Bloomberg: HUVR IN Breakout Growth Hindustan Unilever (HUVR) has delivered strong volume led top-line growth

More information

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in

More information

The Ramco Cements. Institutional Equities. Event Update BUY

The Ramco Cements. Institutional Equities. Event Update BUY Event Update The Ramco Cements 21 December 2018 Reuters: TRCE.BO; Bloomberg: TRCL IN Capacity Expansion To Boost Its Presence In Andhra & Telangana The Ramco Cements (TRCL) has announced 3.15mt cement

More information

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018 3QFY18 Result Update Institutional Equities Manappuram Finance 9 February 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN The Glitter Is Back In Gold Loans Manappuram Finance (MFL) reported its 3QFY18 results

More information

Institutional Equities

Institutional Equities 2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of

More information

93,707 77,814 90, NIM

93,707 77,814 90, NIM 1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven

More information

Institutional Equities

Institutional Equities 3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare

More information

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY. 3QFY18 Result Update Institutional Equities IFB Industries Reuters: IFBI.BO; Bloomberg: IFBI IN Healthy Revenues, Strong Gross Margin; Retain Buy IFB Industries (IFB) posted a healthy 17% YoY rise in net

More information

3,746 2,551 3, NIM

3,746 2,551 3, NIM 4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or

More information

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Dabur India 2 August 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Consistency Is Key To The Game Dabur India s (DABUR) operating performance in 1QFY19 was better

More information

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Sequent Scientific 13 August 2018 Reuters: SEQU.BO; Bloomberg: SEQ IN Regulatory Changes And Adverse Forex Movement Dampens Momentum Sequent Scientific or SSL s revenues at Rs2,369mn

More information

2,09,057 1,85,859 2,17, (4.1) NIM

2,09,057 1,85,859 2,17, (4.1) NIM 2QFY19 Result Update Institutional Equities State Bank of India 6 November 2018 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Credit Growth Improves Materially State Bank of India (SBI) reported its 2QFY19

More information

9,500 7,914 8, NIM

9,500 7,914 8, NIM 3QFY18 Result Update Institutional Equities Federal Bank 16 January 2018 Reuters: FED.BO; Bloomberg: FB IN Quarter Typifies Balanced Growth Engine Federal Bank (FBL) reported 3QFY18 results with the key

More information

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL Company Interaction & Event Update Institutional Equities Tech Mahindra 7 March 2017 Reuters: TEML.BO; Bloomberg: TECHM IN Broadly Maintain Our Outlook On Organic Growth And Margins We interacted with

More information

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA Result Update Institutional Equities The India Cements 28 May 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Fall In Realisation, Higher Operating Costs Hurt Performance The India Cements (ICEM) reported a weak

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)

More information

18,948 15,784 18, NIM

18,948 15,784 18, NIM 3QFY18 Result Update IndusInd Bank 12 January 2018 Reuters: INBK.BO; Bloomberg: IIB IN Alive to all Opportunities IndusInd Bank (IBL) reported its 3QFY18 results with the key strategic takeaways being

More information

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update 3QFY15 Result Update Institutional Equities Bajaj Electricals 13 February 2015 Reuters: BJEL.BO; Bloomberg: BJE IN Final Phase Of Transition Pain; Retain Buy Bajaj Electricals (BJE) posted 3QFY15 revenue

More information

Institutional Equities

Institutional Equities Event Update Institutional Equities Aurobindo Pharma 10 September 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN Acquires Dermatology and Oral Solids Businesses Of Sandoz Aurobindo Pharma s (APL) acquisition

More information

Initiating Coverage. Uflex Ltd.

Initiating Coverage. Uflex Ltd. 2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and

More information

Infosys. Institutional Equities. 2QFY19 Result Update ACCUMULATE

Infosys. Institutional Equities. 2QFY19 Result Update ACCUMULATE Result Update Infosys 17 October 218 Reuters: INFY.BO; Bloomberg: INFO IN Strongest TCV Ever, But At A Cost; We Like The Growth Focus Shrugging itself off from a turbulent 217, Infosys recorded best ever

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 22 May 218 Healthy Performance Led By Good Volume Growth Dalmia Bharat Enterprises (DBEL) reported a healthy performance for

More information

Punjab National Bank

Punjab National Bank 4QFY15 Result Update Institutional Equities Punjab National Bank 11 May 2015 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Disappointment Continues Punjab National Bank (PNB) posted dismal 4QFY15 performance,

More information

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY. 3QFY18 Result Update Institutional Equities Muthoot Finance 12 February 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Funding Cost Decline Combines With Operating Leverage Muthoot Finance (MFL) reported its

More information

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017 1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)

More information

Institutional Equities

Institutional Equities 10 April 2019 4QFY19 Result Preview Gains Versus El Nino Headwind Holds The Key; Retain Buy We remain positive on and retain our Buy call on it based on 24% upside to our blended target price of Rs1,134

More information

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514 3QFY15 Result Update Institutional Equities Cadila Healthcare 11 February 2015 Reuters: CADI.BO; Bloomberg: CDH IN Stable Performance Cadila Healthcare s (CHL) 3QFY15 earnings were in line with our expectations

More information

Institutional Equities

Institutional Equities Company Update Institutional Equities Dr. Reddy s Laboratories 5 September 2017 Reuters: REDY.BO; Bloomberg: DRRD IN Suboxone Generic Opportunity To Be Lucrative, Can Sustain For Longer Time The district

More information

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)

More information

Punjab National Bank

Punjab National Bank 1QFY16 Result Update Institutional Equities Punjab National Bank 29 July 2015 Reuters: PNB.BO; Bloomberg: PNB IN Some Respite On Asset Quality Front Punjab National Bank (PNB) reported moderate 1QFY16

More information

Institutional Equities

Institutional Equities Management Meet Update Institutional Equities Kaya Reuters: KAYA.NS; Bloomberg: KAYA IN We interacted with the management of Kaya at an investor conference held by us recently. Following are the key takeaways:

More information

Punjab National Bank

Punjab National Bank 1QFY18 Result Update Institutional Equities Punjab National Bank 3 August 2017 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Continues To Disappoint Punjab National Bank s (PNB) annualised loan slippage

More information

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536 4QFY17 Result Update La Opala RG 11 May 217 Reuters: LAOP.BO; Bloomberg: LOG IN Revenues Soar, But Margins Take A Hit La Opala RG (LORL) reported revenues of Rs761mn for 4QFY17, up 41% YoY. The stellar

More information

E&P To Stay Strong; Consumer Segment To Revive

E&P To Stay Strong; Consumer Segment To Revive Management Meet Update Institutional Equities Bajaj Electricals 30 August 2017 Reuters: BJEL.BO; Bloomberg: BJE IN E&P To Stay Strong; Consumer Segment To Revive We had a meeting with the management of

More information

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1% Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent

More information

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature. 2QFY19 Result Update Institutional Equities PNB Housing Finance 6 November 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Relatively Soft Quarter Not Structural In Nature PNB Housing Finance (PNBHF) reported

More information

Institutional Equities

Institutional Equities Economy Update Institutional Equities May Inflation/April Index of Industrial Production 13 June 2018 CPI Inflation At 4.9%; IIP Growth Also At 4.9% Consumer Price Index or CPI inflation in India stood

More information

9,251 7,812 8, NIM

9,251 7,812 8, NIM 4QFY15 Result Update Institutional Equities IndusInd Bank 17 April 2015 Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Robust Performance IndusInd Bank s 4QFY15 profit beat our estimate by 12%. Its bottom-line

More information

Institutional Equities

Institutional Equities 4QCY18 Result Update Cognizant Technology Solutions 8 February 2019 Bloomberg: CTSH US Weak 2019 Guidance; US Big Banks Still Soft; New Outsider CEO Cognizant Technology Solutions (CTS) 4QCY18 results

More information

EBITDA 5,019 4,211 5, EBITDA

EBITDA 5,019 4,211 5, EBITDA Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment

More information

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018 2QFY19 Result Update Institutional Equities Muthoot Finance 10 December 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Weak quarter not structural in any way Muthoot Finance (MFL) reported its 2QFY19 results

More information

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017 Management Meet Update Atul Auto 23 August 2017 Reuters: ATUL.BO; Bloomberg: ATUL IN We had a meeting with the management of Atul Auto (AAL) recently to gauge its performance in the aftermath of a relatively

More information

Infosys. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Sector: Information Technology CMP: Rs1,171 Target price: Rs1,157 Downside: 1.

Infosys. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Sector: Information Technology CMP: Rs1,171 Target price: Rs1,157 Downside: 1. Result Update Infosys 14 April 2018 Reuters: INFY.BO; Bloomberg: INFO IN Past Underinvestment Comes Back To Bite; Renewal TCV Skew Poses Growth Risk; Capital Return To Support Stock The performance of

More information

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update 2QFY19 Result Update Institutional Equities Hindustan Unilever 15 October 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Best Proxy In A VUCA World Hindustan Unilever s (HUVR) overall performance in 2QFY19 was

More information

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY 3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &

More information

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018 1QFY19 Result Update Institutional Equities South Indian Bank 23 July 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Performance Troughs, Pessimism Peaks South Indian Bank (SBL) reported 1QFY19 results with

More information

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY Management Meet Update Institutional Equities Bata India 25 June 2018 Reuters: BATA.BO; Bloomberg: BATA IN Likely Getting Into A Virtuous Cycle We had a meeting with the management of Bata India (BIL)

More information

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY 3QFY19 Result Update State Bank of India 4 February 2019 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Growth Continues To Accelerate State Bank of India (SBI) reported its 3QFY19 results with the key pointers

More information